FES-Cycling With Blood Flow Restriction for SCI/D Patients
Official title: Assessing the Safety and Feasibility of Functional Electrical Stimulation Cycling Coupled With Blood Flow Restriction in a Spinal Cord Injury Population
Run by Toronto Rehabilitation Institute · NCT07588503 · Data updated 2026-11-12
This study tests safe and feasible use of functional electrical stimulation cycling with blood flow restriction in adults with spinal cord injury to see if it can help reduce cardiometabolic risk.
Quick facts
| Phase | Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 6 (estimated) |
| Sponsor | Toronto Rehabilitation Institute Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | June 15, 2026 |
| Main results expected | January 1, 2027 |
| Study ends | September 30, 2027 |
| Registry record updated | May 14, 2026 |
| Trial ID | NCT07588503 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 18–75 with chronic SCI (C5–T10), AIS A–D, at least 1 year post-injury, and multiple cardiometabolic risk factors.
✕Probably not a fit
Individuals without cardiometabolic risk factors or those with the listed exclusion conditions may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 1 trial evaluates the safety and practicality of combining FES-Cycling with blood flow restriction in people with spinal cord injury. Eligible adults with chronic SCI (C5–T10) and multiple cardiometabolic risk factors will participate in a structured, moderate-intensity aerobic program using FES-assisted cycling while cuffs modestly restrict blood flow. Researchers will monitor safety, tolerability, and feasibility, including adverse events and adherence, to inform future efficacy studies. The study builds on preliminary data suggesting BFR can enhance muscle burden and metabolic responses in SCI/D patients. The trial is conducted at the Lyndhurst Centre in Toronto, led by Dr. B. Catharine Craven, with CAN-TAP-TALENT collaboration.
Why it matters
Potential benefit: If successful, participants may experience improved cardiometabolic risk factors and better engagement in aerobic exercise.
How similar studies have gone: Prior small studies suggest BFR with exercise is feasible in SCI/D, but this project uniquely tests moderate-intensity BFR-augmented FES cycling.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult (≥ 18 to ≤ 75yrs) * Male or female * Chronic Injury (\>1yr) * Diagnosis of SCI at levels between C5 to T10 (AIS A-D) with traumatic or non-traumatic etiology. * ≥3 Cardiometabolic risk parameters Exclusion Criteria: * A prior or current history of venous thromboembolism * Pressure injury of the pelvis, mid to upper thigh region, or foot * Managing a lower limb fracture * Any history of embolic stroke * Myocardial infarction * Current untreated hypertension * Language, psychiatric, cognitive, or communicative disability (e.g., traumatic brain injury) that compromises the participant's autonomy to voluntarily join the study, follow its instructions and/or operate the device. * Current alcohol or street drug use disorder. * Current use of an anticoagulant medication. * Frequent episodes of autonomic dysreflexia unresponsive to therapy (e.g., 3-5 times a week). * Unresolved deep vein thromboembolism (VTE) in the past six months. * Severe spasticity preventing the necessary range of motion for cycling. * Active implantable medical device (e.g., pacemaker, ITB pump). * Inability to provide informed consent. * Severe active concurrent medical conditions (e.g., skin or respiratory infections, lung, pressure sores). * Unstable spine or unhealed limbs or pelvic fractures. * Active heterotopic ossification interfering with the lower extremity range of motion.
Where it's running
-
Lyndhurst Centre
Toronto, Ontario, Canada Recruiting
Study contacts
- Study coordinator: Thomas P Walden, Ph.D
- Email: thomas.walden@uhn.ca
- Phone: 4165973422
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Implanted Brain-Computer Interface to Help People with Severe Arm Impairment
We’re testing the N1 System, a fully implanted brain interface in the motor cortex with a robot, to see if it can help adults with spinal cord injury, ALS, or chronic stroke use a computer or keyboard more easily.
-
tSCS with rehabilitation for improving movement after spinal cord injury
This study tests whether adding rehabilitation training to transcutaneous spinal cord stimulation helps paraplegic patients regain voluntary movement after spinal cord injury.
-
Informational Needs of Caregivers of Patients in Neuro Rehab: Validating the QBI-R/V
This study tests a caregiver questionnaire (QBI-R and QBI-V) to see how well it measures caregivers’ informational needs during neuromotor rehabilitation.
-
Biomechanical and Perceived Effort in Manual Wheelchair Propulsion
This study tests whether combining objective shoulder loading data with how hard people feel they’re working can reveal how difficult manual wheelchair propulsion is for users with spinal cord injury.
-
Shockwave therapy added to toxin injections to help spasticity after spinal cord injury
Aims to see if focused shockwave therapy plus Botox injections reduce spasticity better than Botox alone in adults with spinal cord injury.
-
Vibratory Genital Nerve Stimulation to Help Female Sexual Function After Spinal Cord Injury
This study tests whether a home-use vibration device can improve sexual function in cisgender women with spinal cord injury by increasing genital blood flow during arousal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.